ICCVAM: Not Doing Enough

Regulation of nanotechnology: Are we doing enough?

the Nanotechnology Task Force of the Food and Drug Administration (FDA) of the United States released a report which addressed the regulatory challenges presented by products that use nanotechnology (FDA 2007). Since most of these potential products involve nanomaterial interactions with biological tissues, this report directly speaks to the fi eld of nanomedicine. A general fi nding of the rep...

Severe sepsis management are we doing enough?

For the first time in medical history, a drug has been shown to reduce the mortality associated with sepsis, the leading cause of death in many ICUs. Optimal use by appropriate selection of patients and early recognition of sepsis could save thousands of lives. Nurses play a major role in recognizing severe sepsis. By using the concepts introduced here, nurses can play a direct role in saving t...

Are We Doing Enough for Our Field ?

Correspondents Argentina: O. Civitaresse, La Plata; Australia: A. W. Thomas, Adelaide; Austria: H. Oberhummer, Vienna; Belgium: M. Huyse, Leuven; Brasil: M. Hussein, Sao Paulo; Bulgaria: D. Balabanski, Sofia; Canada: J.-M. Poutissou, TRIUMF; K. Sharma, Manitoba; J. Simpson, Guelph; China: W. Zhan, Lanzhou; Croatia: R. Caplar, Zagreb; Czech Republic: J. Kvasil, Prague; Slovak Republic: P. Povine...

Peadiatric Tuberculosis: Is the World Doing Enough?

Data Privacy: Are Operating Systems Doing Enough?

In this paper, we evaluate operating systems for their support for user-data privacy. Our studies at three different installations indicate that current levels of user education and OS support are astonishingly poor. For example, at one installation of 836 users, we were able to access over 86 GB of private data, including more than 300,000 emails, using simple scanning techniques. Along with t...